Loading...
Loading...
All product recalls associated with CAPITOL.
Total Recalls
136
Past Year
21
Class I (Serious)
20
Most Recent
Oct 2025
Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.
ITG Voma Corporation (ITG Voma) is recalling certain Capitol Precision Trac II tires, sizes 245/70R17, 235/70R16, 235/75R15, 245/70R16, 245/75R16, 255/70R16, and 265/75R16. The affected tires may experience a tread separation.
The firm is distributing the Rejuvenator device without an approved 510(k).
American Pacific Industries, Inc. (API) is recalling certain Gladiator brand truck and trailer tires of various sizes. These tires did not pass quality control and are deemed to be unsafe for road service.
Presence of Particulate Matter; Particulates identified as stainless steel and barium sulfate.
Lack of Assurance of Sterility: All compounded products.
Rapiscan Systems, Inc. (Rapiscan) is recalling certain model year 2011-2012 M60 mobile cargo and vehicle inspection systems. In the affected vehicles, due to overtightening, the mounting hardware for the structure that deploys and stows the x-ray scanner may fail, allowing the structure to separate from the vehicle.
Beijing Capital Tyre Co. (BCT) is recalling certain Autoguard LT245/75R16 tires manufactured June 25th, 2012, through November 11th, 2012. These tires failed the endurance test standards of FMVSS 139 and contain incorrect maximum load load data on the sidewall. Thus, these tires fail to to comply to the requirements of Federal Motor Vehicle Safety Standard No. 139, "New Pneumatic Radial Tires for Light Vehicles."
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.